bioRxivMolecular BiologyPreprint
CRISPRδ: dCas13-mediated translational repression for accurate gene silencing in mammalian cells
Antonios ApostolopoulosiD, Hitomi TsuijiiD, Yuichi ShichinoiD, Shintaro IwasakiiD
Abstract
Current gene silencing tools based on RNA interference (RNAi) or, more recently, clustered regularly interspaced short palindromic repeats (CRISPR)Cas13 systems, have critical drawbacks, such as off-target effects (RNAi) or collateral mRNA cleavage (CRISPRCas13). Thus, a more specific method of gene knockdown is needed. Here, we developed "CRISPR{delta}", an approach for translational silencing, harnessing catalytically inactive Cas13 proteins (dCas13). Owing to its tight association with mRNA, dCas13 serves as a physical roadblock for scanning ribosomes during translation initiation and does not affect mRNA stability. Guide RNAs covering the start codon lead to the highest efficacy regardless of the translation initiation mechanism: cap-dependent or internal ribosome entry site (IRES)-dependent translation. Strikingly, genome-wide ribosome profiling revealed the extremely high gene knockdown specificity of CRISPR{delta}. Moreover, fusion of a translational repressor to dCas13 ensured further improvement of the knockdown efficacy. Our method provides a framework for translational repression-based gene silencing in eukaryotes.
- organism: mouse
- assay: CRISPR screen
- research focus: perturbation response prediction
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Engineering improved Cas13 effectors for targeted post-transcriptional regulation of gene expression
E. J. Charles, S. E. Kim, … D. F. Savage·bioRxiv·May 26, 2021
- CRISPR-Cas13 mediated Knock Down in Drosophila cultured cells.
Raghuvir Viswanatha, Michela Zaffagni, … Sebastián Kadener·bioRxiv·Nov 1, 2020
- CRISPR/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells
Yuxi Ai, Dongming Liang, Jeremy E. Wilusz·Nucleic Acids ResearchPeer-reviewed·Feb 21, 2022
- Cytosolic CRISPR RNA for RNA-targeting CRISPR-Cas systems
Ezra C.K. Cheng, Jodie Lam, S. Chul Kwon·EMBO ReportsPeer-reviewed·Feb 26, 2025
- Optimizing a CRISPR-Cas13d gene circuit for tunable target RNA downregulation with minimal collateral RNA cutting
Yiming Wan, Christopher Helenek, … Gábor Balázsi·ACS Synthetic BiologyPeer-reviewed·Oct 8, 2024
- Leveraging CRISPR-Cas13d in an inducible knockdown system to interrogate Drosophila germ granule mRNAs
Zoya A. Gauhar, Aaron J. Duthoy, … Elizabeth R. Gavis·bioRxiv·Sep 9, 2024